Federal Register Notice: On the request of the Department of Defense (DoD) FDA is extending the Emergency Use Authorization (for Anthrax Vaccine Adsorbed (AVA), issued on 1/27, for preventing inhalation anthrax for individuals between 18 and 65 years of age who are deemed by DoD to be at heightened risk of exposure due to attack with anthrax. To view this notice, click here.
